AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2017
Jun 13, 2017
10196_dirs_2017-06-13_f0cf421a-5678-4260-9412-1f80dbd96d60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2017-06-09
Reporting Person: Ashley Robert A. (Chief Technical Officer, EVP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-09 | Common Stock | P | 2000 | $3.18 | Acquired | 2000 | Direct |
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23